PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30178570-0	2019	Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.	Sitagliptin Phosphate	23-34	insulin	Homo sapiens	125-132	
30178570-3	2019	At week 24, the between-group difference (sitagliptin - placebo) in the least squares mean (95% confidence intervals) change from baseline in HbA1c in patients using premixed insulin was -0.43% (-0.58, -0.28), P <0.001.	Sitagliptin Phosphate	42-53	insulin	Homo sapiens	175-182